Fertility and Sterility
Volume 90, Issue 6 , Pages 2165-2171 , December 2008

The incidence of both serious and minor complications in young women undergoing oocyte donation

  • Kara N. Maxwell, M.D., Ph.D.

      Affiliations

    • Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, New York
    • ,
  • Ina N. Cholst, M.D.

      Affiliations

    • Center for Reproductive Medicine and Infertility, Weill Cornell Medical College, New York, New York
    • Corresponding Author InformationReprint requests: Ina N. Cholst, M.D., Reproductive Medicine, The Center for Reproductive Medicine and Infertility, Weill Cornell Medical College, 1305 York Avenue, 7th Floor, New York, New York 10021.
    • ,
  • Zev Rosenwaks, M.D.

      Affiliations

    • Center for Reproductive Medicine and Infertility, Weill Cornell Medical College, New York, New York

Received 2 August 2007 ,Revised 26 October 2007 ,Accepted 26 October 2007.

References 

  1. Van Voorhis BJ. Clinical practice. In vitro fertilization. N Engl J Med. 2007;356:379–386
  2. Wright VC, Chang J, Jeng G, Macaluso M. Assisted reproductive technology surveillance–United States, 2003. MMWR Surveill Summ. 2006;55:1–22
  3. Centers for Disease Control and Prevention . 2004 Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006;
  4. Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril. 1987;47:895–909
  5. Tarlatzis BC, Pados G. Oocyte donation: clinical and practical aspects. Mol Cell Endocrinol. 2000;161:99–102
  6. Soderstrom-Anttila V. Pregnancy and child outcome after oocyte donation. Hum Reprod Update. 2001;7:28–32
  7. Kalfoglou AL. Navigating conflict of interest in oocyte donation. Am J Bioeth. 2001;1:W1;Available at: http://www.bioethics.net/journal/j_articles.php?aid=334
  8. Robertson JA. Ethical and legal issues in human embryo donation. Fertil Steril. 1995;64:885–894
  9. Resnik DB. The commodification of human reproductive materials. J Med Ethics. 1998;24:388–393
  10. Lidz CW, Appelbaum PS, Grisso T, Renaud M. Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med. 2004;58:1689–1697
  11. Mastroianni L. Risk evaluation and informed consent for ovum donation: a clinical perspective. Am J Bioeth. 2001;1:28–29
  12. Practice Committee of the American Society for Reproductive Medicine. Repetitive oocyte donation. Fertil Steril. 2004;82(Suppl 1):S158–S159
  13. Sauer MV. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Am J Obstet Gynecol. 2001;184:277–278
  14. Davis OK, Rosenwaks Z. Superovulation strategies for assisted reproductive technologies. Semin Reprod Med. 2001;19:207–212
  15. Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod. 1997;12:2359–2365
  16. Benadiva CA, Davis O, Kligman I, Moomjy M, Liu HC, Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril. 1997;67:724–727
  17. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44:430–440
  18. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8:559–577
  19. Abramov Y, Elchalal U, Schenker JG. Severe OHSS: an “epidemic” of severe OHSS: a price we have to pay?. Hum Reprod. 1999;14:2181–2183
  20. Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol. 1998;77:239–243
  21. Roest J, Mous HV, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update. 1996;2:345–353
  22. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril. 1998;70:638–642
  23. Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online. 2006;12:153–162
  24. Sauer MV, Paulson RJ. Mishaps and misfortunes: complications that occur in oocyte donation. Fertil Steril. 1994;61:963–965
  25. Sauer MV, Paulson RJ, Lobo RA. Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors. Int J Gynaecol Obstet. 1996;52:259–262
  26. Halme J, Toma SK, Talbert LM. A case of severe ovarian hyperstimulation in a healthy oocyte donor. Fertil Steril. 1995;64:857–859
  27. Rosenberg H, Epstein Y. Follow-up study of anonymous ovum donors. Hum Reprod. 1995;10:2741–2747
  28. Kalfoglou AL, Gittelsohn J. A qualitative follow-up study of women's experiences with oocyte donation. Hum Reprod. 2000;15:798–805
  29. Sung L, Bustillo M, Mukherjee T, Booth G, Karstaedt A, Copperman AB. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril. 1997;67:912–916

 I.N.C. served on the speaker's bureau for Merck. All other authors have nothing to disclose.

PII: S0015-0282(07)03951-9

doi: 10.1016/j.fertnstert.2007.10.065

Fertility and Sterility
Volume 90, Issue 6 , Pages 2165-2171 , December 2008

Article Tools